Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. PEB offers services such as molecular oncology, bioinformatics, cancer genetics, clinical research, technology commercialisation, marketing and sales, among others. The company offers diagnostic services through its facilities located in Australia, New Zealand, and the US. PEB is headquartered in Dunedin, New Zealand.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pacific Edge Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides a detailed description of products in development, technical specifications and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Pacific Edge Ltd Company Overview
- Pacific Edge Ltd Company Snapshot
- Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Pacific Edge Ltd - Pipeline Analysis Overview
- Pacific Edge Ltd - Key Facts
- Pacific Edge Ltd - Major Products and Services
- Pacific Edge Ltd Pipeline Products by Development Stage
- Pacific Edge Ltd Pipeline Products Overview
- Cxbladder - Health
- Cxbladder - Health Product Overview
- Cxbladder - Prognosis Assay
- Cxbladder - Prognosis Assay Product Overview
- Cxcolorectal - Prognosis Gen I
- Cxcolorectal - Prognosis Gen I Product Overview
- Cxcolorectal - Prognosis Gen II
- Cxcolorectal - Prognosis Gen II Product Overview
- Diagnostic Assay - Gastric Cancer
- Diagnostic Assay - Gastric Cancer Product Overview
- Endometrial Cancer Detection Assay
- Endometrial Cancer Detection Assay Product Overview
- Gastric Cancer Triage Immunoassay
- Gastric Cancer Triage Immunoassay Product Overview
- Prognostic Assay - Melanoma
- Prognostic Assay - Melanoma Product Overview
- Pacific Edge Ltd - Key Competitors
- Pacific Edge Ltd - Key Employees
- Pacific Edge Ltd - Locations And Subsidiaries
- Head Office
- Other Locations &Subsidiaries
- Recent Developments
- Pacific Edge Ltd, Recent Developments
- Nov 21, 2019: Pacific Edge announces FY20 results and capital raising
- May 29, 2019: Pacific Edge reports continued growth in FY19
- May 20, 2019: International Urology experts present on Cxbladder
- Apr 18, 2019: Pacific Edge appoints John Duncan to the Board as an Independent Director
- Mar 18, 2019: Cxbladder adoption roll-out advances in New Zealand
- Aug 16, 2018: Another of New Zealand’s Public Healthcare providers, Hauora Tairawhiti, adopts Cxbladder
- May 29, 2018: Pacific Edge Announces Preliminary Results for Year Ended 31 March 2018
- May 24, 2018: Cxbladder Monitor Demonstrates Clinical Utility In Patients Being Monitored For Recurrent Bladder Cancer (UC)
- Nov 29, 2017: Pacific Edge: FY18 Interim Results
- Aug 03, 2017: Cxbladder Test Suite Adopted by MidCentral DHB
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
List of Tables
- Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Pacific Edge Ltd Pipeline Products by Equipment Type
- Pacific Edge Ltd Pipeline Products by Indication
- Pacific Edge Ltd, Key Facts
- Pacific Edge Ltd, Major Products and Services
- Pacific Edge Ltd Number of Pipeline Products by Development Stage
- Pacific Edge Ltd Pipeline Products Summary by Development Stage
- Cxbladder - Health - Product Status
- Cxbladder - Health - Product Description
- Cxbladder - Prognosis Assay - Product Status
- Cxbladder - Prognosis Assay - Product Description
- Cxcolorectal - Prognosis Gen I - Product Status
- Cxcolorectal - Prognosis Gen I - Product Description
- Cxcolorectal - Prognosis Gen II - Product Status
- Cxcolorectal - Prognosis Gen II - Product Description
- Diagnostic Assay - Gastric Cancer - Product Status
- Diagnostic Assay - Gastric Cancer - Product Description
- Endometrial Cancer Detection Assay - Product Status
- Endometrial Cancer Detection Assay - Product Description
- Gastric Cancer Triage Immunoassay - Product Status
- Gastric Cancer Triage Immunoassay - Product Description
- Prognostic Assay - Melanoma - Product Status
- Prognostic Assay - Melanoma - Product Description
- Pacific Edge Ltd, Key Employees
- Pacific Edge Ltd, Subsidiaries
- Glossary
List of Figures
- Pacific Edge Ltd Pipeline Products by Equipment Type
- Pacific Edge Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Metlifecare Ltd
- Fisher & Paykel Healthcare Corporation Ltd
- Arborgen Holdings Ltd
